Effect of Dexmedetomidine and Midazolam on postoperitive delirium in elderly patients:a systematic review

Jun ZHOU,Long WANG,Yi GUO,Qin ZHOU
DOI: https://doi.org/10.3969/j.issn.1003-6350.2015.02.0098
2015-01-01
Abstract:Objective To evaluate the effect of Dexmedetomidine and Midazolam on postoperitive delir-ium in elderly patients by Meta-analysis. Methods Trials were collected through searches of PubMed, SCI, EM-base, the Cochrane Library, CNKI, CBM, VIP and Wanfang databases (From the date of establishment of the data-bases to December 2013) for randomized controlled trials (RCT) on the effect of Dexmedetomidine and Midazol-am on postoperitive delirium in elderly patients. The included studies were evaluated with criteria by two research-ers independently and the extracted data were analyzed by RevMan 5.2. Results Six RCT studies involving 170 old patients met the inclusion criteria. The results of meta-analysis showed that,compared with the Midazol-am-treated patients, the prevalence of delirium was lower in Dexmedetomidine-treated patients [RR=0.17, 95%CI (0.09, 0.30), P<0.000 01]. Conclusion The incidence of delirium in Dexmedetomidine-treated patients is lower than that in the Midazolam-treated patients. However, due to the few included RCTs and small samples, especially the lower quality of included RCTs, more large-samples, high-quality RCTs are required for further verify.
What problem does this paper attempt to address?